Drugs / Sodium Propionate
Sodium Propionate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07611370 | Sep 2026 → Jun 2027 expected | cancer, graft versus host disease, hematopoietic and lymphoid system neoplasm | City of Hope Medical Center | Not yet recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04700527 Comparator | Dec 2023 → Apr 2027 expected | poisoning, radiation-induced disorder | UNC Lineberger Comprehensive Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Propionate | “Sodium butyrate and sodium propionate” NCT04700527 ↗ |
| Known as | E281 | ChEMBL registry synonym — accepted as the source's own label CHEMBL500826 ↗ |
| Known as | SODIUM PROPIONATE MONOHYDRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL500826 ↗ |
| Modality | Small molecule | — CHEMBL500826 ↗ |
| Route | Oral | “Given PO” NCT07611370 ↗ |